𝔖 Bobbio Scriptorium
✦   LIBER   ✦

983 Steatosis is a cofactor for fibrosis and response to therapy in genotype 1B chronic hepatitis C (CHC)

✍ Scribed by CAMMA, C; DIMARCO, V; CAMOZZI, M; BRUNO, S; DIBONA, D; RUMI, M; VINCI, M; MONDELLI, M; INFETTIVE, M; COLOMBO, M

Book ID
123052356
Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
110 KB
Volume
38
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Low vitamin D serum level is related to
Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C
✍ Salvatore Petta; Calogero CammΓ ; Concetta Scazzone; Claudio Tripodo; Vito Di Mar πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 543 KB

25-Hydroxyvitamin D (25[OH]D) can potentially interfere with inflammatory response and fibrogenesis. Its role in disease progression in chronic hepatitis C (CHC) and its relation with histological and sustained virological response (SVR) to therapy are unknown. One hundred ninety-seven patients with

HBV genotype B is associated with better
HBV genotype B is associated with better response to interferon therapy in HBeAg( + ) chronic hepatitis than genotype C
✍ Chun Tao Wai; Chi-Jen Chu; Munira Hussain; Anna S. F. Lok πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 579 KB

Hepatitis B virus (HBV) genotype and precore/core promoter mutations have been implicated in spontaneous and interferon alfa (IFN-+related hepatitis B e antigen (HBeAg) seroconversion. We performed a retrospective analysis of a previously reported randomized controlled trial to determine the effects

Development and validation of two models
Development and validation of two models for early prediction of response to therapy in genotype 1 chronic hepatitis C
✍ Eva MartΓ­nez-Bauer; Javier Crespo; Manuel Romero-GΓ³mez; Ricardo Moreno-Otero; Ri πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 250 KB πŸ‘ 1 views

Early prediction of response to therapy in genotype 1 chronic hepatitis C is difficult. Two predictive models, a pretreatment scoring model (PreT-SM) and a fourth week of therapy scoring model (4w-SM) were constructed in a cohort of 104 patients from a single center (estimation cohort) and validated